Law360 Highlights the Top 5 Multidistrict Litigation Matters of 2016

Law360 Highlights the Top 5 Multidistrict Litigation Matters of 2016

Law360 reviews a list of “Top 5 Multidistrict Litigation Matters,” covering large-scale cases “sure to make headlines in 2017,” all of which include some involvement by Lieff Cabraser. These highly visible multi-district litigation matters include: General Motors Ignition-Switch defects, DePuy Pinnacle Hip injuries, Xarelto (Rivaroxaban) blood thinner injuries, Volkswagen “Clean Diesel” Emissions consumer fraud, and Pelvic Surgical Mesh injuries. [Read more…]

Xarelto Litigation Scheduling Order Sets Injury Cases in Motion

Xarelto Litigation Scheduling Order Sets Injury Cases in Motion

On April 21, 2016, Judge Eldon E. Fallon, the federal judge supervising and overseeing the centralized litigation against Janssen, Johnson & Johnson and Bayer over Xarelto, issued an order scheduling the depositions of plaintiffs and defense witnesses. The court is overseeing the discovery necessary to develop several “bellwether” trials in order to evaluate the strength and weaknesses of the cases brought against the pharmaceutical giants and to determine the values of certain harms and injuries. [Read more…]

Xarelto Bleed Injury Timeline Updates and Patient Information

Xarelto bleeding injury lawsuits timeline

Drug’s Release in 2011 Leads to Thousands of Serious Injuries by 2014, Consolidated Lawsuits Through 2015

Xarelto was released in July 2011 to prevent blood clots in patients undergoing knee and hip surgeries, and its use was then expanded to include patients with irregular heartbeats or facing likely lung and leg blood clots. It was also used to prevent clots in some people with atrial fibrillation. The drug is taken as a pill with the chemical name rivaroxaban. The new Xarelto patient information injury and lawsuit timeline shown below tracks Xarelto from its release to thousands of patient injury reports less than two years later, to thousands of Xarelto death and uncontrolled bleeding injury lawsuits slated for bellwether treatment in 2016 and 2017. [Read more…]

Wendy Fleishman Discusses Dangerous Side Effects from Xarelto

Wendy Fleishman Discusses Dangerous Side Effects from Xarelto

Patients charge that Xarelto is a dangerous and defective drug because in certain patients it triggers uncontrolled bleeding and other life-threatening complications. Xarelto was approved in July 2011 to prevent blood clots in patients undergoing knee and hip surgeries, and its use has been expanded, including to patients with irregular heartbeats or facing a strong likelihood of blood clots in the legs or lungs.

[Read more…]

Xarelto Blood Thinner Lawsuits Consolidated in Louisiana Federal Court

Patients Allege Xarelto Linked to Serious Bleeding Risk

Wendy R. Fleishman of the national plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP, announced today that nearly two dozen lawsuits filed against Johnson & Johnson subsidiary Janssen Pharmaceuticals and Bayer Corp. over the blood thinner Xarelto have been consolidated in Louisiana federal court. The U.S. Judiciary Panel on Multidistrict Litigation found that the cases have enough common complaints to warrant centralization. Xarelto has been linked to serious side effects including gastrointestinal bleeding, brain bleeding, other internal bleeds, and death. [Read more…]